# PRSWeave run R4180a893

**Request:** Using the published polygenic score provided (PGS005206) and the genotype dosage file provided for 20 individuals, compute a validated polygenic score for total-body BMD for each individual and report the results with their limitations.

**Final state:** REQUIRES_HUMAN_REVIEW. The independent validator rejected release of PGS005206 scores as total-body BMD (criteria V6b and V7; no retry allowed). The PGS Catalog trait fields for PGS005206 say only 'Bone mineral density' with no skeletal site; total body comes only from the linked source GWAS GCST005348 (Total body bone mineral density). The only catalogued evaluation is in a European paediatric cohort (Generation R, n=3470, mean age 9.77 years), and predictive validity cannot be assessed on the synthetic dosages. Do you approve treating PGS005206 as a total-body BMD score on the basis of the source GWAS and releasing the 20 raw scores in artifacts/prs_scores_1.csv with these limitations, or should the run stop without releasing results?

Planner decisions: 9; tool executions: 6; Critic reviews: 1 ['FAIL']; recovery cycles: 0.

## Decision sequence

| Step | Action | Status |
|---|---|---|
| S001 | inspect_score_metadata | ok |
| S002 | assess_phenotype_compatibility | ok |
| S003 | inspect_variant_coverage | ok |
| S004 | validate_effect_alleles | ok |
| S005 | approve_plan | ok |
| S006 | verify_checksum | ok |
| S007 | calculate_prs | ok |
| S008 | submit_for_validation | FAIL |
| S009 | request_human_review | ok |

## Fixed limitations

- Genotypes are synthetic effect-allele dosages; no ancestry, phenotype or real allele harmonization.
- PGS005206 is a total-body BMD score; nothing here is a hip-BMD result.
- Derivation of the published weights is partly unverified (DR-0002).
- Raw weighted sums only; no percentiles, risk categories or clinical meaning.
